Cargando…
Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study
BACKGROUND: Hyperkalemia is a common and potentially life-threatening electrolyte disorder in maintenance hemodialysis (MHD) patients. This study aimed to evaluate the efficacy and safety of potassium-lowering regimens during treatment of acute hyperkalemia in MHD patients. METHODS: This retrospecti...
Autores principales: | Yao, Lan, Xing, Xiaoyang, Li, Yubao, Zhang, Fangxing, Li, Ping, Liang, Xianhui, Wang, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310460/ https://www.ncbi.nlm.nih.gov/pubmed/35879718 http://dx.doi.org/10.1186/s12967-022-03530-4 |
Ejemplares similares
-
Real-World Evaluation of Patiromer for the Treatment of Hyperkalemia in Hemodialysis Patients
por: Kovesdy, Csaba P., et al.
Publicado: (2018) -
Course of Hyperkalemia in Patients on Hemodialysis
por: Spinowitz, Bruce, et al.
Publicado: (2022) -
Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia
por: Huang, Chien-Wei, et al.
Publicado: (2015) -
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
por: Bushinsky, David A, et al.
Publicado: (2015) -
The burden of hyperkalemia in Germany – a real world evidence study assessing the treatment and costs of hyperkalemia
por: Haas, Jennifer Scarlet, et al.
Publicado: (2020)